Citius Pharmaceuticals, Inc.

CTXR · NASDAQ
Analyze with AI
6/30/2025
3/31/2025
12/31/2024
9/30/2024
Assets
Cash & Equivalents$6,089$26$1,100$3,252
Short-Term Investments$0$0$0$0
Receivables$0$0$0$0
Inventory$17,209$15,339$14,381$8,269
Other Curr. Assets$1,313$3,009$2,846$2,700
Total Curr. Assets$24,611$18,374$18,327$14,221
Property Plant & Equip (Net)$881$922$191$246
Goodwill$9,347$9,347$9,347$9,347
Intangibles$92,800$92,800$92,800$92,800
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$92,838$38$38$38
Total NC Assets$103,066$103,107$102,376$102,431
Other Assets$0$0$0$0
Total Assets$127,677$121,481$120,703$116,652
Liabilities
Payables$10,094$9,368$7,364$4,927
Short-Term Debt$229$145$205$242
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$41,519$40,363$37,237$30,646
Total Curr. Liab.$51,842$49,877$44,806$35,815
LT Debt$767$787$0$21
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$7,507$7,242$6,978$6,714
Other NC Liab.$0$0$0$0
Total NC Liab.$8,273$8,029$6,978$6,735
Other Liabilities$0$0$0$0
Cap. Leases$882$932$205$263
Total Liabilities$60,116$57,906$51,784$42,550
Equity
Pref Stock$0$0$0$0
Common Stock$14$9$8$7
Retained Earnings-$230,845-$222,055-$211,138-$201,370
AOCI$0$0$0$0
Other Equity$295,889$282,706$276,539$271,440
Total Equity$65,059$60,659$65,408$70,077
Supplemental Information
Minority Interest$2,502$2,916$3,511$4,024
Total Liab. & Tot. Equity$127,677$121,481$120,703$116,652
Net Debt-$5,093$905-$896-$2,989
Citius Pharmaceuticals, Inc. (CTXR) Financial Statements & Key Stats | AlphaPilot